Lirimilast, CAS [[329306-27-6]]

Produktübersicht

• Artikelname: Lirimilast, CAS [[329306-27-6]]
• Artikelnummer: MCE-HY-19672
• Hersteller Artikelnummer: HY-19672
• Alternativnummer: MCE-HY-19672-5MG,MCE-HY-19672-100MG,MCE-HY-19672-10MG,MCE-HY-19672-10MMX1ML,MCE-HY-19672-50MG,MCE-HY-19672-25MG,MCE-HY-19672-1MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: BAY 19-8004

Produktbeschreibung

Lirimilast (BAY 19-8004) is a potent, selective and orally active phosphodiesterase-4 (PDE4) inhibitor with an IC50 value of 49 nM. Lirimilast can be used for the treatment of asthma or chronic obstructive pulmonary disease (COPD). Lirimilast has potently anti-inflammatory properties[1][2].

Produkteigenschaften

• Molekulargewicht: 443.26
• Reinheit: 98.69
• CAS Nummer: [329306-27-6]
• Formel: C17H12Cl2N2O6S
• Target-Kategorie: Phosphodiesterase (PDE)

Anwendungsbeschreibung

• Anwendungsbeschreibung: Reference compound